Diseases [C] » Eye Diseases [C11] » Eye Diseases, Hereditary » Retinitis Pigmentosa
Diseases [C] » Eye Diseases [C11] » Retinal Diseases » Retinal Degeneration » Retinal Dystrophies » Retinitis Pigmentosa
Diseases [C] » Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16] » Genetic Diseases, Inborn » Eye Diseases, Hereditary » Retinitis Pigmentosa
Description
Hereditary, progressive degeneration of the retina due to death of ROD PHOTORECEPTORS initially and subsequent death of CONE PHOTORECEPTORS. It is characterized by deposition of pigment in the retina. MeSH
Hierarchy View
Subtype Terms (4)
Alstrom Syndrome
2 drugs (1 approved, 1 experimental)
Bardet-Biedl Syndrome
2 approved drugs
Usher Syndromes
4 experimental drugs
Phase 2 Indicated Drugs (14)
Other Experimental Indicated Drugs (2)
Organization Involved with Phase 3 Indications (5)
Organization Involved with Phase 2 Indications (52)
Applied Genetic Technologies Corp
Beirut Eye Specialist Hospital
California Institute for Regenerative Medicine (CIRM)
Casey Eye Institute, Portland, Oregon
Ophthalmic Consultants of Boston
Retina Foundation of the Southwest
Organization Involved with Phase 1 Indications (17)
Organization Involved with Other Experimental Indications (1)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.